nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anti-angiogenic agents for NSCLC following first-line immunotherapy: Rationale, recent updates, and future perspectives
|
Reck, Martin |
|
|
179 |
C |
p. |
artikel |
2 |
Antimuscarinics and lung cancer survival: A Norwegian population-based cohort study
|
Sanjinez, Claudia |
|
|
179 |
C |
p. |
artikel |
3 |
Clinical application of the AMOY 9-in-1 panel to lung cancer patients
|
Kunimasa, Kei |
|
|
179 |
C |
p. |
artikel |
4 |
Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases
|
Fassi, Elena |
|
|
179 |
C |
p. |
artikel |
5 |
Clinicopathologic features, tumor immune microenvironment and genomic landscape of EBV-related and EBV-unrelated poorly differentiated nonkeratinizing squamous cell carcinoma of the thymus
|
Zhang, Yi-Jun |
|
|
179 |
C |
p. |
artikel |
6 |
Comparative effectiveness of mobocertinib and standard of care in patients with NSCLC with EGFR exon 20 insertion mutations: An indirect comparison
|
Ou, Sai-Hong I. |
|
|
179 |
C |
p. |
artikel |
7 |
Contents
|
|
|
|
179 |
C |
p. |
artikel |
8 |
Cost-effectiveness analysis of adjuvant atezolizumab in stage II-IIIA non-small cell lung cancer expressing ≥50% PD-L1: A United Kingdom health care perspective
|
Yip, Chui-ying |
|
|
179 |
C |
p. |
artikel |
9 |
CT-derived body composition associated with lung cancer recurrence after surgery
|
Gezer, Naciye S. |
|
|
179 |
C |
p. |
artikel |
10 |
Emergency presentation prior to lung cancer diagnosis: A national-level examination of disparities and survival outcomes
|
Gurney, Jason |
|
|
179 |
C |
p. |
artikel |
11 |
Flavored E-cigarette product aerosols induce transformation of human bronchial epithelial cells
|
Tellez, Carmen S. |
|
|
179 |
C |
p. |
artikel |
12 |
Genomic and transcriptomic insights into the precision treatment of pulmonary enteric adenocarcinoma
|
Liu, Yuan |
|
|
179 |
C |
p. |
artikel |
13 |
How much have covid-19 pandemic waves impacted the number of lung cancer surgeries
|
da Cunha, Amanda Ramos |
|
|
179 |
C |
p. |
artikel |
14 |
Identification of inflamed-phenotype of small cell lung cancer leading to the efficacy of anti-PD-L1 antibody and chemotherapy
|
Shirasawa, Masayuki |
|
|
179 |
C |
p. |
artikel |
15 |
Indirect comparison of mobocertinib and real-world therapies for pre-treated non-small cell lung cancer with EGFR exon 20 insertion mutations
|
Christopoulos, Petros |
|
|
179 |
C |
p. |
artikel |
16 |
In regard to wandrey et al
|
Sari, Sezin Yuce |
|
|
179 |
C |
p. |
artikel |
17 |
Management, risk factors and prognostic impact of checkpoint-inhibitor pneumonitis (CIP) in lung cancer – A multicenter observational analysis
|
Frost, Nikolaj |
|
|
179 |
C |
p. |
artikel |
18 |
New pathogenic germline variants identified in mesothelioma
|
Belcaid, Laila |
|
|
179 |
C |
p. |
artikel |
19 |
Occupational asbestos exposure and survival among lung cancer patients
|
Noelle, Hugo |
|
|
179 |
C |
p. |
artikel |
20 |
Publisher’s note
|
|
|
|
179 |
C |
p. |
artikel |
21 |
Real-world treatment patterns and outcomes of patients with metastatic nonsquamous non-small cell lung cancer after progression on standard-of-care therapy in the United States
|
Divan, Hozefa A. |
|
|
179 |
C |
p. |
artikel |
22 |
Slipping through the cracks: Who is eligible but does not receive a healthcare provider recommendation for lung cancer screening?
|
Williamson, Timothy J. |
|
|
179 |
C |
p. |
artikel |
23 |
To fly or not to fly: Stereotactic MR-guided adaptive radiotherapy effectively treats ultracentral lung tumors with favorable long-term outcomes
|
Regnery, Sebastian |
|
|
179 |
C |
p. |
artikel |
24 |
Tumor response like pseudo-progression to lenvatinib in advanced thymic carcinoma
|
Ito, Koki |
|
|
179 |
C |
p. |
artikel |
25 |
Use of radiation therapy among patients with Extensive-stage Small-cell lung cancer receiving Immunotherapy: Canadian consensus recommendations
|
Sun, Alexander |
|
|
179 |
C |
p. |
artikel |